COA/RE-2026-001Verified
Save as PDFCertificate of Analysis
PuriLab Analytical
RT20+ELO5 25 mg
RE-2026-001Lot NOT PROVIDEDAnalyzed November 20, 2026

Timeline
Ordered
November 9, 2026
Received
November 13, 2026
Analyzed
November 20, 2026
Sample
Name
RT20+ELO5 25 mg
Expected
RT20+ELO5 (Retatrutide, Eloralintide)
Amount
1 vial, lyophilized powder
Testing
Client
3A Labz
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
Retatrutide21.21mg
Label claim: 20 mg
Eloralintide6.20mg
Label claim: 5 mg
Purity, how clean it is
97.1%
by HPLC-UV peak area, system peaks excluded
Chromatogram
HPLC-UV
12.91 min, Eloralintide
13.65 min, Retatrutide
Analyst Comments
White lyophilized powder, purple-cap vial, received sealed.
Analyst Signature
Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 20, 2026
Verification Code
RE-8Y26-35C6
Verify at purilab.org/verify/RE-8Y26-35C6
Scan to Verify
RE-8Y26-35C6
Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.
PuriLab Analytical|admin@purilab.org
Page 1 of 1